China Health : VOLUNTARY ANNOUNCEMENT

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

CHINA HEALTH GROUP INC.

中國醫療集團有限公司

(Carrying on business in Hong Kong as "萬全醫療集團") (Incorporated in the Cayman Islands with limited liability)

(Stock Code: 08225)

VOLUNTARY ANNOUNCEMENT OF PROPOSED TRANSFER OF LISTING

FROM GEM TO THE MAIN BOARD OF

THE STOCK EXCHANGE OF HONG KONG LIMITED

This announcement is made by China Health Group Inc. (the "Company", together with its subsidiaries, the "Group") pursuant to Rule 17.10(2)(a) of the Rules Governing the Listing of Securities on GEM (the "GEM Listing Rules") of The Stock Exchange of Hong Kong Limited (the "Stock Exchange") and the Inside Information Provisions (as defined in the GEM Listing Rules) under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).

The board (the "Board") of directors (the "Directors") is pleased to announce that the Company is considering the possibility of seeking a transfer of listing of all of the Company's shares (the "Shares") from GEM to the Main Board of the Stock Exchange (the "Possible Transfer of Listing") pursuant to Chapter 9A of the Rules Governing the Listing of Securities on the Stock Exchange. The Company has appointed a sponsor for the Possible Transfer of Listing. The Company believes that, if materialized, the listing of Shares on the Main Board of the Stock Exchange will be beneficial to the future growth, financing flexibility, and business development of the Group. As at the date of this announcement, no formal application has been made to the Stock Exchange in respect of the Possible Transfer of Listing. Further announcements will be made by the Company to keep its shareholders and potential investors informed of the progress of the Possible Transfer of Listing as and when required under the GEM Listing Rules.

1

As at the date of this announcement, there is no definite timetable or execution plan with respect to the Possible Transfer of Listing, which may or may not materialise. The Possible Transfer of Listing is subject to, among other things, the application to, and approval from, the Stock Exchange and may or may not proceed. Potential investors and shareholders of the Company are advised to exercise caution when dealing in the securities of the Company.

By order of the Board

China Health Group Inc.

GUO Xia

Chairman

Hong Kong,8 May 2020

As at the date hereof, the Board comprises two executive Directors, being Mr. GUO Xia and Dr. SONG Xuemei; one non-executive Director, being Mr. SU Yi; and three independent non-executive Directors, being Mr. QIU Rui, Dr. NI Binhui and Mr. ZHEN Ling.

This announcement, for which the Directors collectively and individually accept full responsibility, includes particulars given in compliance with the GEM Listing Rules for the purpose of giving information with regard to the Company. The Directors, having made all reasonable enquiries, confirm that to the best of their knowledge and belief the information contained in this announcement is accurate and complete in all material respects and not misleading or deceptive, and there are no other matters the omission of which would make any statement herein or this announcement misleading.

This announcement will remain on the "Latest Listed Company Information" page of the GEM website at http://www.hkgem.com for 7 days from the date of its posting. This announcement will also be posted on the Company's website at http://www.chgi.net.

2